Michael Lytton Leaves Oxford Bioscience Partners for Biogen, Inc.
2/26/2009 8:12:48 AM
More...
|
Safeguard Scientifics (SFE) and Oxford Bioscience Partners Co-Lead $12 Million Series a Financing for Molecular Biometrics
11/10/2008 7:24:28 AM
More...
|
Oxford Bioscience Partners Promotes Dr. Douglas Fambrough to General Partner
9/19/2007 10:42:04 AM
More...
|
Oxford Bioscience Partners Raises $20 Million In Private Placement
10/19/2005 5:12:59 PM
More...
|
ImpactRx And Majestic Research Announce Innovative Research Partnership
10/19/2005 5:12:41 PM
More...
|
Sirna Therapeutics (RNAI) Raises $6.8 Million In Warrant Exercise In Support Of New RNAi Product Development Opportunities
10/19/2005 5:11:34 PM
More...
|
Evotec OAI (Germany) (DX:EVT) To Expand Agreement With Oxford Bioscience Partners Through Integration Of Its New Rational Drug Design Platform, EVOrationale
10/19/2005 5:11:03 PM
More...
|
Jeffrey Barnes, General Partner At Oxford Bioscience Partners, Will Give "State Of The Medical Technology Industry" Address At Medtech Insight's Boston "Investment In Innovation" Investment And Partnering Conference
10/19/2005 5:10:48 PM
More...
|